Skip to main content

Statera Biopharma, Inc.

STABDelisted Mar 3, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001318641

Statera Biopharma, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Oct 28, 2021; 29 institutions reported holding it in 13F filings for Q4 2022, worth $197.5K in total; no superinvestor held it.

Q3 2021 vs. Q2 2021

How the institutions holding Statera Biopharma, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of STAB: Q2 2021 compared with Q3 2021
MeasureQ2 2021Of which not filed for Q3 2021Q3 2021Change
Holders21123+3
Shares787.5K4381.22M+431.5K (+54.8%)
Value$4.31M$2.00K$2.81M−$1.49M (−34.6%)

1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (8)

Institutions that held Statera Biopharma, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to STAB in Q3 2021
InstitutionSharesValue% of portfolio
UBS Group AG19,470$45.0K0.00%
Dowling & Yahnke LLC14,675$34.0K0.00%
Tower Research Capital LLC (TRC)13,891$32.0K0.00%
Virtu Financial LLC13,185$30.0K0.00%
Charles Schwab Investment Management Inc12,170$29.0K0.00%
Raymond James Financial Services Advisors, Inc.12,250$28.0K0.00%
State Street Corp11,047$26.0K0.00%
Harbour Investments, Inc.1,381$3.00K0.00%

Sold out (5)

Institutions that held Statera Biopharma, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of STAB in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Sequoia Financial Advisors, LLC12,588$69.0K
Royal Bank of Canada3,620$20.0K
US Bancorp1,000$5.00K
IFP Advisors, Inc150$1.00K
Orion Capital Management LLC50$0

Not filed for Q3 2021 yet (1)

Institutions that held Statera Biopharma, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding STAB in Q2 2021 that haven't filed for Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
CWM, LLC438$2.00K